Does volume change of the spleen correlate with the therapy response in uveal melanoma patients with liver metastases undergoing hepatic artery infusion chemotherapy?
In uveal melanoma patients with liver metastases undergoing HAIC, neither the change of SV nor splenomegaly could be identified as prognostic factors for OS.
Authors
- Luca Salhöfer (ORCID: https://orcid.org/0000-0002-5376-3154)
- Marcel Opitz (ORCID: https://orcid.org/0000-0001-7455-8590)
- M Drews (ORCID: https://orcid.org/0009-0003-9825-3136)
- Benedikt M. Schaarschmidt (ORCID: https://orcid.org/0000-0001-6331-7679)
- Johannes Haubold (ORCID: https://orcid.org/0000-0003-4843-5911)
- Natalie van Landeghem (ORCID: https://orcid.org/0009-0009-5391-6550)
- Heike Richly
- Sebastian Zensen (ORCID: https://orcid.org/0000-0003-2997-0740)
- Jens Thomas Siveke (ORCID: https://orcid.org/0000-0002-8772-4778)
- Michael Forsting (ORCID: https://orcid.org/0000-0002-5584-9824)
- Yan Li (ORCID: https://orcid.org/0000-0002-9403-9533)
- Hannah L Steinberg‐Vorhoff (ORCID: https://orcid.org/0000-0003-4848-4166)
- Mathias Holtkamp
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Essen University Hospital (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Radiology and Oncology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2478/raon-2025-0047
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00